Sinha Rashmi, Racette Brad, Perlmutter Joel S, Parsian Abbas
Department of Pediatrics, UMAS College of Medicine, Little Rock, AR, USA.
Parkinsonism Relat Disord. 2005 Sep;11(6):341-7. doi: 10.1016/j.parkreldis.2005.04.003.
Mutations in the parkin gene are a common cause of autosomal recessive juvenile parkinsonism (AR-JP) but their role in idiopathic Parkinson's disease (PD) is not clear. Recent studies demonstrate that most young onset PD without family history is not due to mutations in parkin. However, there is less information about the role of this gene in older onset PD. The objective of the present study was to evaluate the prevalence and frequency of parkin gene mutations and variations in the general population of patients with PD categorized on the basis of family history and age of onset. We sequenced a sample of 50 familial PD patients, screened a sample of 429 PD patients, and 115 normal controls for the previously reported mutations, deletions, single nucleotide polymorphisms (SNP) in exons 2-12 of the parkin gene, and performed RT-PCR of exon 1. A total of two heterozygous mutations in exon 7 (R275W; 0.2%) were detected in the PD group, but none were found in controls. No mutation or deletion was observed in exons 2, 3, 5, 6, 8, 9 or 12. There was also no deletion or duplication of exon 1. The SNPs in exon 4, 10, and 11 that cause amino acid changes were very rare (1-5%). We did not find the exon 4 variation in the controls while allele frequencies were similar among PD patients and controls in exon 10 and 11 polymorphisms. Mutations were not associated with a positive family history of PD or younger age of onset. We concluded that no new mutation, nor the previously described parkin polymorphisms or known mutations, are playing any direct role in the development of PD in this group of PD patients.
帕金森病基因(parkin)突变是常染色体隐性少年型帕金森病(AR-JP)的常见病因,但其在特发性帕金森病(PD)中的作用尚不清楚。近期研究表明,大多数无家族病史的年轻型帕金森病并非由parkin基因突变所致。然而,关于该基因在老年型帕金森病中的作用,相关信息较少。本研究的目的是评估根据家族病史和发病年龄分类的帕金森病患者总体人群中parkin基因突变和变异的患病率及频率。我们对50例家族性帕金森病患者样本进行了测序,对429例帕金森病患者样本及115例正常对照进行筛查,检测parkin基因外显子2 - 12中先前报道的突变、缺失、单核苷酸多态性(SNP),并对外显子1进行逆转录聚合酶链反应(RT-PCR)。在帕金森病组中共检测到外显子7中的两个杂合突变(R275W;0.2%),但在对照组中未发现。在外显子2、3、5、6、8、9或12中未观察到突变或缺失。外显子1也没有缺失或重复。外显子4、10和11中导致氨基酸变化的SNP非常罕见(1 - 5%)。我们在对照组中未发现外显子4变异,而在外显子10和11多态性方面,帕金森病患者与对照组的等位基因频率相似。突变与帕金森病的阳性家族史或发病年龄较小无关。我们得出结论,在这组帕金森病患者中,没有新的突变,也没有先前描述的parkin多态性或已知突变在帕金森病的发生发展中起任何直接作用。